Torsten Haack

Statistics

Publications

Citations

930

H-Index

Active since

2000

Affiliations

Sanofi (Germany)(Current)

Sanofi (France)

Science for Life Laboratory

Uppsala University

Uppsala University Hospital

Torsten Haack is an author at Sanofi (Germany) specializing in pharmacology, glucagon-like peptide-1 receptor agonists, and glucagon receptor agonists.

Publications per year

2000–2021

Publications

Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036

Wayne W. Chan, Scott Wise, Michael D. Kaufman et al. · Cancer Cell · 2011 · 207 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

A novel dual glucagon‐like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo‐controlled first‐in‐human and first‐in‐patient trials

J. Tillner, Maximilian Posch, Frank Wagner et al. · Diabetes Obesity and Metabolism · 2018 · 162 citations

Medicine, Pharmacokinetics, Pharmacology +17

Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists

Andreas Evers, Torsten Haack, M. Lorenz et al. · Journal of Medicinal Chemistry · 2017 · 101 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +17

Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations

Andreas Evers, Martin Bossart, Stefania Pfeiffer‐Marek et al. · Journal of Medicinal Chemistry · 2018 · 51 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes

Olof Eriksson, Torsten Haack, Youssef Hijazi et al. · Scientific Reports · 2020 · 43 citations · Full text

Medicine, Endocrinology, Pharmacology +17

1–5 of 21